These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17960025)

  • 1. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.
    MacDonald ML; Singaraja RR; Bissada N; Ruddle P; Watts R; Karasinska JM; Gibson WT; Fievet C; Vance JE; Staels B; Hayden MR
    J Lipid Res; 2008 Jan; 49(1):217-29. PubMed ID: 17960025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.
    MacDonald ML; van Eck M; Hildebrand RB; Wong BW; Bissada N; Ruddle P; Kontush A; Hussein H; Pouladi MA; Chapman MJ; Fievet C; van Berkel TJ; Staels B; McManus BM; Hayden MR
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):341-7. PubMed ID: 19095997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
    Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL
    Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):24-30. PubMed ID: 19834103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice.
    Mukherjee P; Hough G; Chattopadhyay A; Grijalva V; O'Connor EI; Meriwether D; Wagner A; Ntambi JM; Navab M; Reddy ST; Fogelman AM
    J Lipid Res; 2018 Oct; 59(10):1818-1840. PubMed ID: 30139760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.
    Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL
    Circulation; 2008 Sep; 118(14):1467-75. PubMed ID: 18794388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
    Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
    Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stearoyl-CoA desaturase in body weight regulation.
    Dobrzyn A; Ntambi JM
    Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
    Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
    Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
    Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
    J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice.
    Singh AB; Liu J
    Sci Rep; 2019 Oct; 9(1):15641. PubMed ID: 31666640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
    Dobrzyn A; Ntambi JM
    Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
    Flowers MT; Ntambi JM
    Curr Opin Lipidol; 2008 Jun; 19(3):248-56. PubMed ID: 18460915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
    Flowers MT; Miyazaki M; Liu X; Ntambi JM
    J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.
    Ntambi JM; Miyazaki M; Stoehr JP; Lan H; Kendziorski CM; Yandell BS; Song Y; Cohen P; Friedman JM; Attie AD
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11482-6. PubMed ID: 12177411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
    Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
    J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
    Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.